Suivre
Abonner ALK-Abello

ALK-Abello

Filtre
  • 07.06.2008 – 12:02

    GRAZAX(R) Demonstrates Significant Reductions on Asthma Symptoms in Children

    Barcelona (ots/PRNewswire) - - In Addition to Effects on Allergic Rhinitis (Hayfever), GRAZAX(R) Demonstrated Significant Reductions in Asthma Symptoms in Children Aged 5 to 16 Years Old ALK-Abelló today presented successful results from a new clinical trial, GT-12, designed to measure the impact of GRAZAX(R) on allergic rhinitis and allergic asthma. GT-12 ...